Companies and Salix Pharmaceuticals acknowledged that the Centers for Medicare and Medicaid Services has selected XIFAXAN 550 ...
B ausch & Lomb (NYSE:BLCO) dropped 9% in after hours trading after a report that private equity firm Blackstone may drop out of a group bidding for the eyecare company.